Sponsors

Hepatitis C virus immunoassay

Roche Diagnostics has announced that the Elecsys anti-hepatitis C virus (HCV) assay has received regulatory approval in Europe for the E170 analyser for modular analytics and the e601 module for the Cobas 6000 platform. The Elecsys anti-HCV assay is already available on the Elecsys 2010 and the Cobas e411 instruments.

Hepatitis C virus infection represents a major cause of death through the development of severe fibrosis, cirrhosis and liver cancer. The principal mode of transmission is parenteral exposure to infected blood or blood products (ie insufficient blood screening procedures, mainly in developing countries) and contaminated needles or other invasive medical tools.

Roche
www.roche.com

Latest Issues

2nd Global Summit on Pathology

Rome, Italy
10-11 April, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

LabMedUK25

Bridgewater Hall, Manchester
9-11 June, 2025